A with an increased incidence of neoplasia, with an increase in the incidences of Kaposi's sarcoma and non-Hodgkin's lymphoma estab1i~hed.l.~ Recent reports of bronchogenic carcinoma occurring in young patients who are human immunodeficiency virus (HIV)-seropositi~e~,~ led us to speculate that the tumor also may be associated with AIDS. Acquired immunodeficiency syndrome is predominantly a disease of the younger age groups; 85 percent of AIDS occurs in men 20 to 49 years ~l d .~,~ Although bronchogenic carcinoma is more prevalent in the elderly, it was also known to occur in the younger patients before the HIV e p i d e r n i~.~~, '~ It is possible therefore that these reported cases of bronchogenic carcinoma in the young during the period from 1987 to 1990 (AIDS period) were at-risk patients. The time from 1976 to 1979 was chosen as the pre-AIDS period because no HIV-related diseases had been seen in this institution before 1980. The registry revealed 261 cases of bronchogenic carcinoma in the pre-AIDS period and 232 in the AIDS period. These cases were stratified into four different age groups: 45 years or younger, 46 to 55, 56 to 65, and 66 years or older. The incidences of bronchogenic carcinoma in the different age groups in the pre-AIDS period were compared with the ones in the AIDS period. In addition, all patients aged 45 years or less in the AIDS period were subdivided by HIV risk, and clinical characteristics were compared among the subgroups.
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Chi square was used to test for any differences in the age distribution among patients in the pre-AIDS period versus the AIDS period. The independent-samples t test was used to determine any significant difference in mean ages between the two groups.
H N = human immunodeficiency virus

HIV-infected patients do not reflect an increased
The incidences of bronchogenic carcinoma in preincidence but rather are coincidental diseases.
AIDS (1976) (1977) (1978) (1979) and AIDS (from 1987 to 1990) We compared the incidences of broncho~enic carperiods are shown in Table 1 . There were 261 patients 'inom' in Young patients behVeen the P~~-~~~~ and in the pre-AIDS period: 16 (6.1 percent) were in the the *IDS periods; we also evaluated the 'linical age range of 45 years or younger, 58 (22.2 percent) characteristics of bronchogenic carcinoma in young were in the 46-to 55-year range, g3 (31.8 percent) patients at risk for HIV infection and in young patients were in the 56-to 65-year range and 104 (39.8 percent) without HIV risks during the AIDS period.
were in the group of those greater than 65 years old.
identified. These cases were stratified into age groups: 45 2 12 years with a range from 34 to 80 years. N o significant difference between the mean ages was detected (t value= 1.094, p=0.27). Also, the mean ages of the 45 or younger groups in both periods were 40 +-6 and 40 +-4 years, respectively, with no significant difference (t value = 0.080, p = 0.94).
Of the 19 patients aged 45 or younger in the AIDS period, 17 had medical records available for review. Eight patients had no HIV risk factors, and nine were at risk (all due to intravenous drug abuse). Of these nine HIV-at-risk patients, four tested HIV-positive, two were HIV-negative and three were not tested. Their clinical characteristics are shown in Table 2 .
In the non-HIV-risk group, there were three males and five females with a mean age of 43 2 2 years and a range of 39 to 45 years. Of these, four were smokers (average, 27 pack-years) and, strikingly, four were lifelong nonsmokers. Six had adenocarcinomas: one, stage I; two, stage III; and three, stage IV Two had small cell carcinomas that were in the extensive stage.
In the HIV-at-risk group, there were seven males and two females with a mean age of 38 + 3 years and a range of 34 to 44 years. They were all smokers (average, 26 pack-years and the stage ofbronchogenic carcinoma was advanced in the majority of patients.
An immunodeficiency state has been shown by many studies to increase the risk of cancer in humans. Primary immunodeficiency diseases such as WiskottAldrich syndrome, ataxia telangiectasia, X-linked Bruton's type of agammaglobulinemia, and X-linked lymphoproliferative syndrome are associated with an increased incidence of neoplasia."~' Secondary immunodeficiency induced by immunosuppressive drugs for organ transplantation also has been established to predispose humans to the development of malignancy. The malignancies most increased in these patients are primarily non-Hodgkin's lymphoma."' The surveillance theory of tumorigenesis by the immune system has been proposed in that the immune system acts as a powerful mechanism against neoplasms especially those related to oncogenic v i r~s e s . ' . '~.~~ Clinical observations suggest that this theory applies to the HIV as well. Of the 2,008 cases of AIDS reported to Centers for Disease Control in 1983, nearly 40 percent developed a malignancy during the course of their i l l n e s s . L~~a p o s i ' s sarcoma and nonHodgkin's lymphoma were the most common neoplasms observed. The etiopathogenesis of Kaposi's sarcoma in AIDS patients frequently is associated with cytomegalovirus6~' and non-Hodgkin's lymphoma with Epstein-Barr v i r u~.~.~, '
Other tumors like squamous cell carcinoma of the oral cavity and cloacogenic carcinoma of the anorectum also have been reported to occur in AIDS patients."-'
Findings of bronchogenic carcinoma in young HIVpositive patients led to suggestions that the tumor also may be related to AIDS. The results of our study, however, suggest otherwise. They revealed no increased incidence of bronchogenic carcinoma from 1976 to 1979 (pre-AIDS period) to the period from 1987 to 1990 (AIDS period) and no change in the age distribution. There were also no differences noted in the clinical presentations of the tumor between HIVat-risk (including HIV-positive) patients and non-HIVrisk patients aged 45 years or younger.
These results suggest that bronchogenic carcinoma in young HIV-positive patients is likely not related to HIV infection, but they are rather coincidental diseases. One possible explanation for no increased incidence of bronchogenic carcinoma in AIDS is that the tumor is not related to oncogenic viruses in contrast to Kaposi's sarcoma and non-Hodghn's lymphoma. Therefore, the impaired immunologic surveillance in AIDS is less important for the etiopathogenesis of bronchogenic carcinoma.
